September 2026 Options Now Available For Abbott Laboratories (ABT)

Analysis of Abbott Laboratories (ABT) options reveals potential strategies for investors. Selling a put option at the $115 strike price offers a 5.65% return if the contract expires worthless, with a 75% probability of that outcome. Conversely, a covered call strategy at the $145 strike price could yield an 18.45% return if the stock is called away, though there's a 54% chance the contract expires worthless, resulting in a 7.61% premium boost; implied volatility for the put and call options are 27% and 24%, respectively, while the trailing twelve month volatility is 21%.

Analysis

Abbott Laboratories (ABT), trading at $130.82 per share, presents option-based strategies for investors. Selling the $115.00 strike put contract, currently bid at $6.50, offers a method to potentially acquire shares at an effective cost basis of $108.50, representing an approximate 12% discount to the current market price. Analytical data suggests a 75% probability of this out-of-the-money put expiring worthless, which would allow the seller to realize a 5.65% return on the cash commitment, or 4.27% annualized. Alternatively, for existing ABT shareholders, selling the $145.00 strike call contract, bid at $9.95 with a September 2026 expiration, as a covered call could yield a total return of 18.45% if ABT shares are called away at $145.00. There is a 54% assessed probability of this call expiring worthless; in such a scenario, the investor would retain their shares and the collected premium, equating to a 7.61% return boost (5.75% annualized). The implied volatility for the put option stands at 27% and for the call option at 24%, both exceeding ABT's actual trailing twelve-month historical volatility of 21%. This discrepancy indicates that option premiums may be pricing in expectations of greater future price movements or could offer comparatively richer compensation for option sellers.

Key Decisions for Investors

• Investors considering an entry into Abbott Laboratories (ABT) below the current $130.82 price may find selling the $115.00 strike put attractive, targeting an effective purchase price of $108.50 or a 5.65% premium yield if the option expires worthless, an outcome with a 75% probability.
• Existing ABT shareholders seeking to generate additional income could explore selling the September 2026 $145.00 covered call, which offers a potential 7.61% premium (5.75% annualized if it expires worthless) or an 18.45% total return if the stock is called away, but this strategy caps upside potential above the $145.00 strike.
• The observed implied volatilities of 27% for the put and 24% for the call, relative to the 21% trailing historical volatility, suggest that option selling strategies for ABT might currently offer enhanced premiums, though this also reflects market anticipation of higher future volatility.
• Given the long-dated September 2026 expiration of the described covered call, investors should carefully consider the multi-year commitment and the risk of forfeiting substantial upside if ABT's share price significantly surpasses the $145.00 strike before expiration.